Melanocortin-1 receptor and methods of use
AssigneeOrigene Technologies, Inc.
InventorsYoumin Shu, Xuan Li, Anthony C. Yee, Gilbert Jay
Life of this patent
Estimating the term…
Loading patent…
AssigneeOrigene Technologies, Inc.
InventorsYoumin Shu, Xuan Li, Anthony C. Yee, Gilbert Jay
Estimating the term…
The present invention relates to all facets of novel polynucleotides for melanocortin-1 receptors, the polypeptides they encode, antibodies and specific binding partners thereto, and their applications to research, diagnosis, drug discovery, therapy, clinical medicine, forensic science and medicine, etc. The polynucleotides are useful in variety of ways, including, but not limited to, as molecular markers, as drug targets, and for detecting, diagnosing, staging, monitoring, prognosticating, preventing or treating, determining predisposition to, etc., diseases and conditions especially relating to melanocortin-1, such as melanoma, pigmentation disorders and conditions, inflammation, etc. The identification of a specific genes expressed in pathways physiologically relevant to pigmentation and inflammation permits the definition of functional and disease pathways, and the delineation of targets in these pathways which are useful in diagnostic, therapeutic, and clinical applications.
An isolated polynucleotide comprising, a polynucleotide sequence coding without interruption for a human MCR-1C, or complement thereto,
An isolated polynucleotide coding for a human MCR-1C polypeptide having 95% or more amino acid sequence identity along its entire length to the sequence coding for amino acids 367-398 of SEQ ID NO 2, or a fragment thereof which is specific for said human MCR-1C.
A method of claim 14, wherein said detecting is performed by:
A method of detecting polymorphisms in human MCR-1C comprising:
Dependencies are inferred from the claim text.